KCI Receives Three-Year Contract with Vizient for its Negative Pressure Wound Therapy
KCI, an Acelity Company, the world’s largest wound management company, today announced it has entered into a three-year group purchasing agreement for its leading Negative Pressure Wound Therapy (NPWT) with Vizient Inc., the largest member-driven health care performance improvement company in the United States. Effective October 1, 2018, the agreement helps ensure that Vizient members will have access to the most advanced wound care technologies supported by superior clinical and economic outcomes for their patients.
“Strong loyalty and long-term relationships with customers like Vizient help us achieve our mission to improve the lives of the patients who need our therapies,” said Rohit Kashyap, President, Americas. “Our new contract with Vizient enhances our commitment to making our NPWT systems accessible. KCI is a leader in the market in part because of our rapid innovation program and superior medical education platforms, and we will continue to develop and expand our strengths so that we can offer our customers the most advanced solutions in wound care.”
About KCI, an Acelity Company
KCI, an Acelity Company, the most trusted brand in advanced wound care, is committed to developing innovative healing solutions for customers and patients across the care continuum. Our unsurpassed product portfolio is available in more than 90 countries and delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Committed to advancing the science of healing, KCI sets the standard for leading advanced wound therapy innovation. Headquartered in San Antonio, Texas, KCI employs nearly 5,000 people around the world.